FDA classifies recall of CareFusion ventilators as Class 1

The FDA has classified CareFusion’s Sept. 12 recall of 128 EnVe ventilators as Class 1. The company said in a statement that the recall and update affect 29 CareFusion customers who purchased EnVe units that were manufactured between December 2010 and May 2011.

Among the problems cited in the Sept. 12 notification letter were a potential for disconnection during transport, a potential delay in resuming ventilation after reconnection and a potential automatic reset.

San Diego-based CareFusion said it is updating the hardware and software on the affected devices “in a timely manner with minimal disruption to customers.”

Read the recall notification here.

Dave Pearson

Dave P. has worked in journalism, marketing and public relations for more than 30 years, frequently concentrating on hospitals, healthcare technology and Catholic communications. He has also specialized in fundraising communications, ghostwriting for CEOs of local, national and global charities, nonprofits and foundations.

Around the web

The new technology shows early potential to make a significant impact on imaging workflows and patient care. 

Richard Heller III, MD, RSNA board member and senior VP of policy at Radiology Partners, offers an overview of policies in Congress that are directly impacting imaging.
 

The two companies aim to improve patient access to high-quality MRI scans by combining their artificial intelligence capabilities.